Patrick Baeuerle Cullinan Oncology, Inc. (CGEM) insider trading activity

Patrick Baeuerle is Chief Scientific Officer of Cullinan Oncology, Inc.. Currently has a direct ownership of 76,000 shares of CGEM, which is worth approximately $1.2 Million. The most recent transaction as insider was on Feb 17, 2023, when has been sold 38,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 76K

0% 3M change

0% 12M change

Total Value Held $1.2 Million

Patrick Baeuerle Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 17 2023	BUY Grant, award, or other acquisition	-	38,500 Added 33.62%	76,000 Common Stock
Feb 11 2022	BUY Grant, award, or other acquisition	-	37,500 Added 50.0%	37,500 Common Stock
Sep 08 2021	SELL Open market or private sale	$312,950 $28.45 p/Share	11,000 Reduced 100.0%	0 Common Stock
Sep 08 2021	BUY Exercise of conversion of derivative security	$47,300 $4.3 p/Share	11,000 Added 50.0%	11,000 Common Stock
Aug 10 2021	SELL Open market or private sale	$297,000 $27.0 p/Share	11,000 Reduced 100.0%	0 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	$47,300 $4.3 p/Share	11,000 Added 50.0%	11,000 Common Stock

Also insider at

TCRR

TCR2 THERAPEUTICS INC. Healthcare

Director